Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,370 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD38 marks the exhausted CD8+ tissue-resident memory T cells in hepatocellular carcinoma.
Reolo MJY, Otsuka M, Seow JJW, Lee J, Lee YH, Nguyen PHD, Lim CJ, Wasser M, Chua C, Lim TKH, Leow WQ, Chung A, Goh BKP, Chow PKH, DasGupta R, Yeong JPS, Chew V. Reolo MJY, et al. Among authors: lee j, lee yh. Front Immunol. 2023 Jun 12;14:1182016. doi: 10.3389/fimmu.2023.1182016. eCollection 2023. Front Immunol. 2023. PMID: 37377962 Free PMC article.
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer.
Lim CJ, Nguyen PHD, Wasser M, Kumar P, Lee YH, Nasir NJM, Chua C, Lai L, Hazirah SN, Loh JJH, Khor LY, Yeong J, Lim TKH, Low AWX, Albani S, Chong TW, Chew V. Lim CJ, et al. Among authors: lee yh. Front Immunol. 2021 Jan 29;11:615091. doi: 10.3389/fimmu.2020.615091. eCollection 2020. Front Immunol. 2021. PMID: 33584702 Free PMC article.
IFNγ-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.
Lee YH, Chuah S, Nguyen PHD, Lim CJ, Lai HLH, Wasser M, Chua C, Lim TKH, Leow WQ, Loh TJ, Wan WK, Pang YH, Soon G, Cheow PC, Kam JH, Iyer S, Kow A, Bonney GK, Chan CY, Chung A, Goh BKP, Zhai W, Chow PKH, Albani S, Liu H, Chew V. Lee YH, et al. Cancer Lett. 2023 Jan 1;552:215977. doi: 10.1016/j.canlet.2022.215977. Epub 2022 Oct 21. Cancer Lett. 2023. PMID: 36279983 Free article.
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial.
Kim NH, Moon JS, Lee YH, Cho HC, Kwak SH, Lim S, Moon MK, Kim DL, Kim TH, Ko E, Lee J, Kim SG. Kim NH, et al. Among authors: lee yh. Diabetes Obes Metab. 2024 Jun 10. doi: 10.1111/dom.15705. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38853720
7,370 results